Picture of Pharmesis International logo

BFK Pharmesis International Balance Sheet

0.000.00%
sg flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Pharmesis International, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments14.715.21419.79.48
Net Total Accounts Receivable
Net Total Receivables17.112.714.212.98.31
Total Inventory
Prepaid Expenses
Total Current Assets38.93737.144.233.3
Net Property, Plant And Equipment53.751.853.151.350.2
Net Goodwill
Long Term Investments
Other Long Term Assets
Total Assets93.991.392.797.985.9
Accounts Payable
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities29.232.430.839.630.6
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Liabilities31.83535.24434.8
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity62.156.357.553.951.1
Total Liabilities & Shareholders' Equity93.991.392.797.985.9
Total Common Shares Outstanding